BHC
Bausch Health Companies Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$6.56
−2.96%Aug 12, 2026, 22:30 UTC
Bausch Health Companies Inc. reported Q2 2026 non-GAAP EPS of $1.26, beating consensus by $0.25, with 13% revenue growth and improved margins and cash flow.
Source:Aug 6, 2026, 11:04 UTC
Thomas J. Appio, CEO of Bausch Health, was appointed to the board of directors of Bausch + Lomb Corporation, effective August 5, 2026.
Source:Jul 29, 2026, 20:05 UTC
Bausch Health Companies Inc. announced its second quarter 2026 financial results on July 29, 2026.